Skip to content

Dr. Dumoulein Michiel

Active
Private limited companyfounded 2012active for 14 yearsPeter Benoitlaan 1, 8530 Harelbeke, BelgiumKBO/BCE: BE 0845.649.265

From the official registers: KBO 14 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Dumoulein Michiel has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €238,136. Equity has been growing by about 13% per year since 2018. Its solvency ranks better than 65% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Dr. Dumoulein MichielActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 12-04-2012 Normal situation
Legal form
Private limited company
Registered office
Peter Benoitlaan 1, 8530 Harelbeke
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.212.373.426 8530 Harelbeke, since 19-09-2012
Financial year end
31 December
Peppol
Reachable since 02-11-2024
Company details

Board and ownership

Board
  • DUMOULEIN MichielDirector
Shareholders
Board & ownership

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€395,954
▼ 12.4%
Turnover
≈ €610,000
estimated
Profit
€238,136
▲ 14.4%
Equity
€1.2m
▲ 23.9%
Total assets
€1.6m
▲ 12.9%
2025 accounts filed 10 days before the deadline
Filed on 21-07-2026at the National Bank
Financials
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 5.01, cash €344,679Figures for financial year 2025 (filed on 21-07-2026)Size: total assets €1.6mShow the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 61% of micro companies in human health (NACE 86)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 100+6
equity 76.1% of total assets
Liquidity 74+7
short-term debt 13.5% · cash 21.3%
Profitability 87+17
return on assets 14.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €110,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.01 (4.21 in 2024), above the usual 1.5. Short-term debt is 13.5% and cash 21.3% of total assets. 23.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 56% on liquidity, 39% on profitability and 68% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 5.01, cash €344,679
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 21-07-2026)
NBB · annual accounts
lowers risk · Size: total assets €1.6m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-07-2026, 10 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
10 days early
2024
29 days late
2023
26 days late
2022
12 days early
2021
33 days early
2020
31 days late
2019
8 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 3 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 July (4 of the last 5 filed years within 37 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 95% of companies in human healthsector median €124,628 · 20,680 companies €1.2m View
  • Positive: 8 profitable years in a rowprofit 2025: €238,136 8 years View

Documents

Annual accounts at the NBB

All 14 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Dumoulein Michiel

What is the company number of Dr. Dumoulein Michiel?
The company number of Dr. Dumoulein Michiel is 0845.649.265. The VAT number is the same number with BE in front: BE 0845.649.265.
Where is Dr. Dumoulein Michiel based?
The registered office is at Peter Benoitlaan 1, 8530 Harelbeke.Company details
What does Dr. Dumoulein Michiel do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Dumoulein Michiel?
The legal form of Dr. Dumoulein Michiel is Private limited company (BV).
When was Dr. Dumoulein Michiel founded?
Dr. Dumoulein Michiel was founded on 12-04-2012.
Is Dr. Dumoulein Michiel still active?
Yes, Dr. Dumoulein Michiel is an active enterprise in the KBO register.
What is the turnover of Dr. Dumoulein Michiel?
The turnover in financial year 2025 is ≈ €610,000. This figure is estimated from the gross margin of €395,954 and 36 comparable companies (NACE 862). It probably lies between €550,000 and €770,000.Financials
Is Dr. Dumoulein Michiel profitable?
In financial year 2025, Dr. Dumoulein Michiel made a profit of €238,136.
Where can I find the annual accounts of Dr. Dumoulein Michiel?
Dr. Dumoulein Michiel filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Dumoulein Michiel due?
Dr. Dumoulein Michiel must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as Dr. Dumoulein Michiel: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.4m and €1.7m, founded between 2010 and 2013.

CompanyTotal assetsGross margin
Dr. Dumoulein Michiel Harelbeke€1.6m€0.4m
Dr. Decramer Arne Brugge€1.6m€0.4m
DR. STEVEN CNUDDE Brugge€1.5m€0.4m
Dr. Murielle Herman Roeselare€1.5m€0.4m
SOUFFLET MD Ieper€1.7m€0.4m
Dr. Borny Filip Kortrijk€1.4m€0.4m
Dr. Lammertijn Liesbet, Hematoloog Hasselt€1.5m€0.4m
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure